Global Pharmatech IncOTC Pink - Current Information:GBLP
- LAST PRICE0.1500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1500/ 50
- Ask / Lots0.3500/ 25
- Open / Previous Close0.0000 / 0.1500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Global Pharmatech Inc | 59.3M | -1.6x | --- |
Spectral Medical Inc | 91.5M | -8.2x | --- |
Odonate Inc | 55.0M | -1,384.3x | --- |
Cyclo Therapeutics Inc | 37.0M | -1.0x | --- |
NDT Pharmaceuticals Inc | 41.6M | 0.0x | --- |
Zhong Yuan Bio-Technology Holdings Ltd | 88.4M | 392.2x | --- |
Company Information
Global Pharmatech, Inc., formerly Global Pharmatech Pvt. Ltd., is a contract manufacturer of liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles The Company has manufactured products in various therapeutic segments such as Vitamin Supplements, Anaesthetics, Corticosteroids, Anti-emetics, Steroids with antibiotics, Anemia, Analgesics, Antihistamines, Anti Filarial. Its first product, Iron Sucrose, is being marketed in India. It offers the products for domestic as well as international market. Its products include Iron Sucrose Injection USP, Ondansetron Injection USP, Promethazine Injection BP, Tramadol HCI Injection, Metoclopramide Injection BP, Levetiracetam Injection and Amikacin Injection. The Company registers products in various markets around the world.
Contact Information
- Headquarters
- 509 Maoxiang Street High-Tech Development AreaCHANGCHUN, JLN, China 130012
- Phone
- ---
- Fax
- ---
Executives
- Chairwoman of the Board, President, Chief Executive Officer
- Lianqin Qu
- Chief Financial Officer
- Zongsheng Zhang
- Director
- Zhenyou Zhang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $59.3M |
|---|---|
Revenue (TTM) | $3.2M |
Shares Outstanding | 395.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.10 |
Book Value | $0.35 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 18.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
